US Daily Ledger: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on US Daily Ledger.

Press releases published on October 5, 2026

Oct. 5, 2026

BLIA Brings 50,000 Members from 41 Countries Together at Taipei Dome to Mark Historic Buddhist Milestones

Indeterminate EIN Presswire

Oct. 5, 2026

Merlin, Inc. To Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

Oct. 5, 2026

Government Business Results Expands Public Sector Go-to-Market Services with New Partner Marketing Practice

Indeterminate GlobeNewswire

Oct. 5, 2026

Arqitech signs agreement with ThinkEquity to build a multi-asset platform under the ThinkEquity brand

Indeterminate GlobeNewswire

Oct. 5, 2026

Universal Health Services, Inc. Announces Date for Third Quarter 2026 Earnings Release and Conference Call

Indeterminate GlobeNewswire

Oct. 5, 2026

Sprout Social to Announce Third Quarter 2026 Financial Results on November 3, 2026

Indeterminate GlobeNewswire

Oct. 5, 2026

Aligos Therapeutics Announces Five Abstracts Accepted for Presentation at The Liver Meeting® 2026

Indeterminate GlobeNewswire

Oct. 5, 2026

Adeia Renews IP License Agreement with Spectrum

Indeterminate GlobeNewswire

Oct. 5, 2026

Inspire Medical Systems, Inc. to Report Third Quarter 2026 Financial Results on November 2, 2026

Indeterminate GlobeNewswire

Oct. 5, 2026

Alamar Biosciences Names Former Grail CEO Bob Ragusa to Board of Directors and Expands Leadership Team

Indeterminate GlobeNewswire

Oct. 5, 2026

Korro Announces First Cohort Dosed in Phase 1/2 Clinical Trial (ANCHOR) for KRRO-121

Indeterminate GlobeNewswire

Oct. 5, 2026

Standard BioTools Announces Agreement to Sell Microfluidics Business to ARCHIMED

Indeterminate GlobeNewswire

Oct. 5, 2026

Neostellar Capital Corp. Announces Third Quarter 2026 Preliminary Investment Portfolio Update

Indeterminate GlobeNewswire

Oct. 5, 2026

Equillium Receives Australian Regulatory Clearance to Initiate First-in-Human Clinical Trial of EQ504

Indeterminate GlobeNewswire

Oct. 5, 2026

Polar Power Rejects Solidion All-Cash Offer for Company Assets

Indeterminate GlobeNewswire

Oct. 5, 2026

Eledon Pharmaceuticals Announces Presentation at the American Society of Nephrology Kidney Week 2026 Annual Meeting

Indeterminate GlobeNewswire

Oct. 5, 2026

AEVEX Corp. (AVEX) Investors: October 20, 2026, Filing Deadline in Securities Fraud Class Action - Contact Kessler Topaz Meltzer & Check, LLP

Indeterminate GlobeNewswire

Oct. 5, 2026

Leonardo DRS Completes Training and Delivery of INOD Block III Thermal Weapon Sights for the Australian Army

Indeterminate GlobeNewswire

Oct. 5, 2026

iCell Gene Therapeutics Announces Upcoming Conference Presentations

Indeterminate GlobeNewswire

Oct. 5, 2026

ORIC® Pharmaceuticals Announces Agreement with Cancer Research UK to Advance a Potential First-in-Class CIP2A-Targeted Therapy Into Clinical Development

Indeterminate GlobeNewswire